Ribosomal Protein L17 Activators
Ribosomal Protein L17 Activators refers to a class of chemical compounds or molecules that exert their influence on the activation or functional modulation of Ribosomal Protein L17 (RPL17). RPL17 is a critical component of the ribosome, the cellular machinery responsible for protein synthesis. Activation of RPL17 is integral to the proper assembly and functioning of ribosomes, which, in turn, play a fundamental role in the translation of genetic information from mRNA into functional proteins. These activators are chemical entities that interact with the cellular and molecular mechanisms involved in the activation and proper functioning of RPL17, thereby impacting the overall efficiency of ribosome-mediated protein synthesis.
Ribosomal Protein L17 activators can function through various mechanisms. They may directly bind to RPL17 or its associated partners, enhancing its stability and facilitating its incorporation into the ribosome. Alternatively, these activators may target upstream or downstream pathways that are intertwined with ribosome biogenesis and RPL17 activation. For example, they could modulate the signaling pathways related to ribosomal RNA transcription, ribosome assembly, or even the cellular availability of nucleotides and amino acids essential for protein synthesis. By influencing these processes, RPL17 activators play a role in ensuring that ribosomes assemble correctly and efficiently, promoting the translation of mRNA into functional proteins. These chemical compounds are integral tools in research and have broad implications for understanding the molecular underpinnings of cellular protein synthesis. They are critical for exploring the intricacies of ribosome function and the role RPL17 plays in this process, shedding light on the complex web of interactions that govern the translation of genetic information into functional proteins within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of the mTOR pathway, which regulates protein synthesis and ribosome biogenesis. By blocking mTOR, rapamycin indirectly stimulates the activation of Ribosomal Protein L17, an essential component of ribosome assembly and function. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
A protein synthesis inhibitor that indirectly promotes the activation of Ribosomal Protein L17 by inhibiting translation. This inhibition can enhance the availability and incorporation of L17 into ribosomes during assembly. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
An RNA polymerase inhibitor that affects rRNA transcription, thereby indirectly encouraging the activation of Ribosomal Protein L17. Reduced rRNA transcription can stimulate ribosome biogenesis. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, a key enzyme in nucleotide biosynthesis. By affecting nucleotide availability, it indirectly promotes the synthesis and activation of Ribosomal Protein L17 during ribosome biogenesis. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
This compound activates changes in nucleotide metabolism and RNA synthesis. By influencing these processes, it indirectly stimulates the synthesis and activation of Ribosomal Protein L17, an integral component of ribosome assembly and function. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin terminates protein synthesis, indirectly promoting the activation of Ribosomal Protein L17. Its action disrupts ongoing translation processes, potentially encouraging the incorporation of L17 into ribosomes. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $122.00 $219.00 | 2 | |
An inhibitor of the p53-MDM2 interaction, Nutlin-3 activates the modulation of p53 activity, which is linked to ribosomal biogenesis. By regulating p53, it indirectly stimulates the synthesis and activation of Ribosomal Protein L17. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, activating changes in sphingolipid metabolism, which indirectly affects the activation of Ribosomal Protein L17 by influencing ribosome biogenesis, as sphingolipids play a role in this process. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
DMSO is a commonly used solvent for drug delivery, activating changes in cellular processes indirectly. It can impact various cellular pathways, including those related to ribosome biogenesis, which in turn may affect the activation of Ribosomal Protein L17. | ||||||
Ethidium bromide | 1239-45-8 | sc-203735 sc-203735A sc-203735B sc-203735C | 1 g 5 g 25 g 100 g | $48.00 $150.00 $588.00 $2086.00 | 12 | |
Ethidium Bromide is a DNA-intercalating agent that has the potential to disrupt rRNA transcription, indirectly activating changes in the activation of Ribosomal Protein L17, which is involved in ribosome assembly. | ||||||